课题基金基金详情
绿荧光蛋白作标记研究伪狂犬病病毒在体内的增殖与分布
结题报告
批准号:
39970559
项目类别:
面上项目
资助金额:
12.0 万元
负责人:
方六荣
依托单位:
学科分类:
C1806.兽医传染病学
结题年份:
2002
批准年份:
1999
项目状态:
已结题
项目参与者:
金梅林、何启盖、吴斌、洪文洲、肖少波、覃雅丽
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
客服二维码
微信扫码咨询
中文摘要
将绿荧光蛋白基因插入伪狂犬病菌病毒(PRV)的非必需基因gG和启动子下游,通过同源重榻浞直鹨隤RV鄂A野毒株、鄂A株TK.
英文摘要
Besides its importance as an animal pathogen, Pseudorabies virus (PRV) has become more and more attractive as a model for studying the pathogenicity and the structure and function of genome at molecular level with the availability of an experimentally accessible natural virus-host system. Recently, Green fluorescent protein (GFP), a novel protein tag, was developed to study viral replication, location and function of a specific protein in live-cell level. In this project, the enhanced GFP (EGFP) will be inserted into the genomic DNA of three typical PRV, i.e., field strain (Ea), mutant strain Ea TK-gG-/LacZ+ and strain Bartha, to obtain three recombinant PRV expressing EGFP to study the replication and distribution of PRV in vivo. .After three years study, the following important results were obtained. (1) An EGFP expression cassette in which the EGFP gene was droved by the promoter of gG of PRV was obtained. This expression cassette can be used to study the function of the specific gene of PRV in the future. (2) Two universal transfer vectors, one locus on gG and another on gE and gI (gE/gI), were constructed, which lay foundation to develop polyvalent vaccines based on PRV. (3) Seven recombinant PRV expressing EGFP or its mutant were obtained, and the results of animal experiments showed that the virulence in vivo of TK-gG- was lower than that of strain Bartha, which indicated that the mutant strain TK-gG- was safe as vaccine and TK was an important factor relating to virulence. (4) Five genes which maybe involve in viral replication and latency were cloned and gC was verified to inhibit viral replication, while gI promote viral replication.The successful completion of this project not only lay foundation to study molecular pathogenicity of PRV, but also represent powerful tools to assess the safety of the existed gene-deleted vaccine and to develop a new generation of safe vaccine. In addition, many important techniques established in this project represent standard techniques for study the function of specific gene.
专著列表
科研奖励列表
会议论文列表
专利列表
猪δ冠状病毒激活钙离子通道SOCE的分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    58万元
  • 批准年份:
    2020
  • 负责人:
    方六荣
  • 依托单位:
猪流行性腹泻病毒nsp7拮抗IFN-β产生及其信号转导的分子机制
  • 批准号:
    31672569
  • 项目类别:
    面上项目
  • 资助金额:
    62.0万元
  • 批准年份:
    2016
  • 负责人:
    方六荣
  • 依托单位:
猪繁殖与呼吸综合征病毒非结构蛋白Nsp1β的SUMO化修饰及其生物学意义
  • 批准号:
    31372467
  • 项目类别:
    面上项目
  • 资助金额:
    85.0万元
  • 批准年份:
    2013
  • 负责人:
    方六荣
  • 依托单位:
猪繁殖与呼吸综合征病毒调控细胞自噬的分子机制及其生物学意义
  • 批准号:
    31172326
  • 项目类别:
    面上项目
  • 资助金额:
    62.0万元
  • 批准年份:
    2011
  • 负责人:
    方六荣
  • 依托单位:
猪繁殖与呼吸综合征病毒调节未折叠蛋白反应的分子机制研究
  • 批准号:
    30972189
  • 项目类别:
    面上项目
  • 资助金额:
    34.0万元
  • 批准年份:
    2009
  • 负责人:
    方六荣
  • 依托单位:
脂筏在猪繁殖与呼吸综合征病毒感染中的作用研究
  • 批准号:
    30770082
  • 项目类别:
    面上项目
  • 资助金额:
    30.0万元
  • 批准年份:
    2007
  • 负责人:
    方六荣
  • 依托单位:
猪繁殖与呼吸综合征病毒GP5胞外区的结构及其免疫学意义
  • 批准号:
    30571385
  • 项目类别:
    面上项目
  • 资助金额:
    25.0万元
  • 批准年份:
    2005
  • 负责人:
    方六荣
  • 依托单位:
猪繁殖与呼吸综合征“自杀性”DNA疫苗研究
  • 批准号:
    30300257
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    21.0万元
  • 批准年份:
    2003
  • 负责人:
    方六荣
  • 依托单位:
国内基金
海外基金